Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis (Q35774090)

10 August 2017

0 references

Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis (English)

1 reference

10 August 2017

1 reference

cervix uterine cancer

1 reference

S H Jee

1

1 reference

10 August 2017

S Y Won

2

1 reference

10 August 2017

J E Yun

3

1 reference

10 August 2017

J E Lee

4

1 reference

10 August 2017

J S Park

5

1 reference

10 August 2017

S S Ji

6

1 reference

10 August 2017

publication date

1 June 2004

1 reference

International Journal of Gynecology and Obstetrics

10 August 2017

published in

1 reference

10 August 2017

volume

85

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

301-308

1 reference

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 codon 72 polymorphism and risk of cervical cancer in UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Homozygous arginine-72 in wild type p53 and risk of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 polymorphism and risk of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 and genetic susceptibility to cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Effect of p53 polymorphism on the susceptibility of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

HLA control in the progression of human papillomavirus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 polymorphism and risk of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 polymorphism and risk of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Papillomavirus and p53 codon 72 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Codon 72 polymorphism of p53 and its association with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

Molecular characterization of adenocarcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2003.08.017

10.1016/J.IJGO.2003.08.017

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference